LS BioPath Overview
- Founded
-
2007
- Status
-
Private
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$6.94M
LS BioPath General Information
Description
Developer of intra-operative imaging device designed for diagnosing breast cancer. The company's simple to operate battery-operated, handheld imaging device de-couples signatures of abnormal from normal tissue during breast cancer surgery and displays them on the device screen, enabling doctors to identify breast tissue abnormalities and reduce the need for repeat surgeries.
Contact Information
Website
www.lsbiopath.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 18809 Cox Avenue
- Suite 140
- Saratoga, CA 95070
- United States
+1 (408) 000-0000
LS BioPath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 06-Jul-2021 | $6.94M | 00.000 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series B) | 10-Mar-2011 | 00.00 | 00.00 | 000.00 | Completed | Startup |
| 1. Early Stage VC (Series A) | 25-Nov-2009 | $700K | $700K | 00.00 | Completed | Startup |
LS BioPath Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 00.000 | |
| Series B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series A | 3,000,000 | $0.001000 | $0.35 | $0.35 | 1x | $0.35 | 13.81% |
LS BioPath Patents
LS BioPath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130230883-A1 | Methods for detection and characterization of abnormal tissue and cells using an electrical system | Granted | 01-Feb-2007 | 000000000 | |
| US-8865076-B2 | Methods for detection and characterization of abnormal tissue and cells using an electrical system | Active | 01-Feb-2007 | 000000000 | |
| US-8417328-B2 | Electrical systems for detection and characterization of abnormal tissue and cells | Active | 01-Feb-2007 | 000000000 | 00 |
| US-8437845-B2 | Electrical methods for detection and characterization of abnormal tissue and cells | Active | 01-Feb-2007 | 000000000 | |
| US-20100106047-A1 | Electrical methods for detection and characterization of abnormal tissue and cells | Granted | 01-Feb-2007 | A61B5/418 |
LS BioPath Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Moshe Sarfaty | Chief Executive Officer | ||
| Rusmin Kudinar | Chief Operating Officer & Board Member |
LS BioPath Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jeff Donnelly | LS BioPath | Board Member | 000 0000 |
| Jim Pfeiffer | LS BioPath | Board Member | 000 0000 |
| Rusmin Kudinar | LS BioPath | Chief Operating Officer & Board Member | 000 0000 |